Corix Bioscience (Corix Bioscience) YoY EBITDA Growth : 62.16% (As of Sep. 2017)

View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Corix Bioscience's YoY EBITDA Growth for the quarter that ended in Sep. 2017 was 62.16%.

Corix Bioscience's EBITDA per Share for the three months ended in Sep. 2017 was $-0.01.

Corix Bioscience YoY EBITDA Growth Historical Data

The historical data trend for Corix Bioscience's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience YoY EBITDA Growth Chart

Corix Bioscience Annual Data

Trend

Jan09

Jan10

Jan11

Jan12

Jan13

Jan14

Jan15

Dec16

YoY EBITDA Growth

Get a 7-Day Free Trial

100.00

39.20

Corix Bioscience Quarterly Data
	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
YoY EBITDA Growth	Get a 7-Day Free Trial															76.28	-530.00	93.48	-50.00	62.16

Corix Bioscience YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Corix Bioscience's YoY EBITDA Growth for the fiscal year that ended in Dec. 2016 is calculated as:

	YoY EBITDA Growth (A: Dec. 2016 )
=	(EBITDA per Share (A: Dec. 2016 )	-	EBITDA per Share (A: Jan. 2015 ))	/	\| EBITDA per Share (A: Jan. 2015 ) \|
=	(-0.456	-	-0.75)	/	\| -0.75 \|
=	39.20 %

Corix Bioscience's YoY EBITDA Growth for the quarter that ended in Sep. 2017 is calculated as:

	YoY EBITDA Growth (Q: Sep. 2017 )
=	(EBITDA per Share (Q: Sep. 2017 )	-	EBITDA per Share (Q: Sep. 2016 ))	/	\| EBITDA per Share (Q: Sep. 2016 )) \|
=	(-0.014	-	-0.037)	/	\| -0.037 \|
=	62.16 %

Corix Bioscience YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Corix Bioscience (Corix Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085

Website

http://www.corixbioscience.com

Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines